Article Text

Reminder of important clinical lesson
Markedly elevated CA19-9 associated with benign ovarian cyst and ascites
  1. Oliver Brain1,
  2. Laura H W Brown2,
  3. Shaila Suvarna3,
  4. Roger Chapman4
  1. 1
    Weatherall Institute of Molecular Medicine, Human Immunology Unit, John Radcliffe Hospital, Headington, Oxford, OX3 9DS, UK
  2. 2
    John Radcliffe Hospital, Geriatrics, Headington, Oxford, OX3 9DU, UK
  3. 3
    John Radcliffe Hospital, Histopathology, Headington, Oxford, OX3 9DU, UK
  4. 4
    John Radcliffe Hospital, Gastroenterology, Headington, Oxford, OX3 9DU, UK
  1. Roger Chapman, Roger.Chapman{at}ndm.ox.ac.uk

Summary

A 60-year-old woman presented after a fall and was noted to have ascites. She had a history of ulcerative colitis. History and physical examination did not reveal the likely aetiology of the ascites, but a sample showed it to be a blood-stained exudate. A malignant cause appeared likely, cross-sectional imaging was arranged and tumour markers sent. CA125 was 34 IU/ml (0–30); α-fetoprotein (AFP) and carcinoembryonic antigen (CEA) were normal. However, CA19-9 was 2880 U/ml (0–31). Pancreatic carcinoma or cholangiocarcinoma were of prime concern, but a CT scan and MRI imaging were normal. At laparoscopy a benign ruptured ovarian cyst was detected, and ascites drained. CA19-9 returned to normal and the patient remains well 9 months later. This case demonstrates how tumour markers may be misleading in the context of diagnostics, and is the highest reported example of CA19-9 rise in the context of benign ascites and benign ovarian pathology.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Competing interests: None.

  • Patient consent: Patient/guardian consent was obtained for publication.